Group | Subgroup | No. of study | HBV/HCV patient | OR(95% CI) | P (OR) | I-squared | P (Heterogeneity) |
---|---|---|---|---|---|---|---|
Controls | LC | 5 | 489 | 1.216 (0.984, 1.502) | 0.070 | 0.0% | 0.457 |
CHC | 4 | 1179 | 1.506 (1.172, 1.936) | 0.001 | 58.2% | 0.067 | |
CHB | 3 | 243 | 1.218 (0.743. 1.997) | 0.434 | 66.1% | 0.052 | |
Healthy | 5 | 1659 | 1.255 (0.899, 1.750) | 0.182 | 68.6% | 0.013 | |
Population-based | HCV-infected patients | 8 | 2452 | 1.326 (1.101, 1.599) | 0.003 | 49.1% | 0.056 |
HBV-infected patients | 3 | 936 | 1.133 (0.718, 1.788) | 0.591 | 72.5% | 0.026 | |
Ethnicity | Asian | 7 | 3135 | 1.273 (1.002, 1.618) | 0.048 | 74.0% | 0.001 |
European | 3 | 3613 | 1.065 (0.787, 1.440) | 0.684 | 0.0% | 0.455 |